JACOBS LEVY EQUITY MANAGEMENT, INC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 89 filers reported holding HARPOON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$630,000
-65.9%
329,842
-11.4%
0.01%
-58.3%
Q1 2022$1,849,000
-25.1%
372,097
+13.9%
0.01%
-29.4%
Q4 2021$2,467,000
+258.6%
326,808
+275.2%
0.02%
+240.0%
Q3 2021$688,000
-35.6%
87,103
+35.3%
0.01%
-44.4%
Q4 2020$1,069,000
-7.8%
64,388
-5.6%
0.01%
-25.0%
Q3 2020$1,159,000
+23.8%
68,225
+21.0%
0.01%
+20.0%
Q2 2020$936,000
+175.3%
56,371
+92.0%
0.01%
+150.0%
Q1 2020$340,00029,3530.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,524,425$58,818,00023.77%
New Leaf Venture Partners, L.L.C. 2,921,405$37,978,00010.18%
EcoR1 Capital, LLC 1,348,423$17,529,0001.77%
SPHERA FUNDS MANAGEMENT LTD. 374,031$4,862,0000.66%
Orbimed Advisors 2,446,409$31,803,0000.49%
Cormorant Asset Management, LP 649,994$8,450,0000.48%
Fosun International Ltd 323,400$4,205,0000.28%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 285,000$3,705,0000.13%
Baker Brothers Advisors 214,285$2,786,0000.02%
UBS Group AG 1,062$14,0000.00%
View complete list of HARPOON THERAPEUTICS INC shareholders